Cancer treatment routinely involves taking out lymph nodes near the tumor in case they contain metastatic cancer cells. But new findings from a clinical trial by researchers at UC San Francisco and Gladstone Institutes shows that immunotherapy can activate tumor-fighting T cells in nearby lymph nodes.
A new tool, developed by UC San Francisco’s Karla Kerlikowske, MD, and colleagues at other institutions, now helps to calculate risk for those who may develop advanced breast cancer that goes undiagnosed despite regular screenings.
The UC San Francisco scientist who developed a successful approach to drugging a protein produced by the mutated KRAS gene has won two prestigious awards in the opening weeks of 2023.
UC San Francisco received the most funding of any public institution from the National Institutes of Health (NIH) in 2022 for the 16th year running. UCSF was second highest among all the public and private institutions in the country.
The UC San Francisco lab of Balyn Zaro, PhD investigates the cause and consequence of genetic diversity in the immune system, in hopes that her discoveries can lead to better treatments for all patients.
A novel UC San Francisco study that aims to transform breast cancer screening is expanding to reach women as young as 30, with the intention of including thousands of women who could be at higher risk of developing aggressive cancer.
UCSF Magazine spotlights Dr. Shawn Hervey-Jumper, a neurosurgeon who specializes in awake brain surgery, in which patients are alert and engaged during parts of the procedure in order to prevent severe brain damage
The transition of a low-grade, slow growing brain tumor to a lethal one can be delayed if neurosurgeons remove as much as possible soon after diagnosis, according to the results of a study led by UC San Francisco.
Using new machine learning techniques, researchers at UC San Francisco, in collaboration with a team at IBM Research, have developed a virtual molecular library of thousands of “command sentences” for cells, based on combinations of “words” that guided engineered immune cells to seek out and tirelessly kill cancer cells.